Table 2. Copy number variants.
| Type | Coordinates | Size (kb) | Dosage | Overlapping genes |
|---|---|---|---|---|
| Gain | chr1: 470 001–600 000 | 130 | 5 | None |
| Gain | chr2: 145 130 001–145 310 000 | 180 | 3 | ZEB2 |
| Gain | chr2: 158 260 001–158 370 000 | 110 | 3 | CYTIP |
| Gain | chr2: 192 770 001–192 940 000 | 170 | 3 | TMEFF2 |
| Gain | chr2: 240 110 001–240 240 000 | 130 | 3 | HDAC4 |
| Gain | chr4: 153 220 001–153 320 000 | 100 | 3 | FBXW7 |
| Gain | chr7: 27 120 001–27 240 000 | 120 | 3 | HOXA gene cluster, MIR196B |
| Gain | chr7: 38 290 001–38 390 000 | 100 | 3 | TARP |
| Gain | chr8: 142 200 001–142 320 000 | 120 | 3 | SLC45A4, DENND3 |
| Gain | chr9: 75 690 001–75 830 000 | 140 | 3 | ANXA1, ALDH1A1 |
| Gain | chr9: 139 420 001–139 520 000 | 100 | 3 | NOTCH1, MIR4674 |
| Gain | chr13: 114 740 001–114 920 000 | 180 | 3 | RASA3 |
| Gain | chr15: 99 410 001–99 510 000 | 100 | 3 | IGF1R |
| Gain | chr17: 80 740 001–80 920 000 | 180 | 3 | TBCD, ZNF750, B3GNTL1 |
| Loss | chr19: 54 070 001–54 200 000 | 130 | 1 | ZNF331, DPRX, MIR520 cluster |
| Gain | chr21: 44 690 001–44 900 000 | 210 | 3 | SIK1 |
| Gain | chr22: 46 380 001–46 550 000 | 170 | 3 | MIRLET7B, MIR3619, MIR4763 |
Tumor-specific copy number variants, dosage and contained genes.